As the October 22 compliance deadline approaches, China’s new individual income tax rules on offshore trusts—a structure widely used by founders of Hong Kong- and U.S.-listed private companies—are raising short-term market risks, according to BofA Securities. Key Takeaways & Market Impact: While unlikely to derail the overall Hong Kong stock index, single-stock volatility remains elevated...
Qatar Investment Authority (QIA), Qatar’s $580 billion sovereign wealth fund, has signed a preliminary agreement with J.P. Morgan Asset Management to launch a $20 billion strategic investment partnership across public and private markets. Key Structure & Allocation: A major cross-border capital deployment cementing sovereign wealth ties with Wall Street asset managers! 🌐💰
Paramount Skydance has reached a landmark settlement with California and 11 other states, eliminating the final major legal obstacle to closing its $110 billion mega-acquisition of Warner Bros. Discovery. Key Settlement Terms & Impact: With regulatory clearances secured across the U.S., EU, and UK, the combined giant gains massive scale to compete with Netflix and...
San Diego-based RNA drug developer ADARx Pharmaceuticals has launched its U.S. initial public offering, seeking a valuation of up to $1.74 billion as momentum builds across clinical-stage biotech listings. Key Data & Offering Highlights: A strong validation of RNA-based therapeutics as big pharma continues to fund advanced clinical innovation! 📊🔬🇺🇸
Chinese regulators (CSRC) have issued informal “window guidance” to pause and raise the bar for humanoid robotics IPOs, seeking to cool market euphoria and ensure valuations reflect real commercial demand rather than state-backed project inflation. Key Takeaways: Beijing remains committed to “embodied intelligence” as a national priority, but is steering the industry from blanket euphoria...
Oura has launched the roadshow for its U.S. initial public offering, targeting a fully-diluted valuation of $15.62 billion to test investor demand for consumer health-tech following a quiet September listing window. Key Data & Offering Details: A decisive benchmark for consumer hardware and subscription health-tech valuations in public markets! 📊💍🇺🇸